Form 8-K - Current report:
SEC Accession No. 0001193125-26-241846
Filing Date
2026-05-27
Accepted
2026-05-27 16:01:51
Documents
16
Period of Report
2026-05-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d228038d8k.htm   iXBRL 8-K 35158
2 EX-4.1 d228038dex41.htm EX-4.1 69612
3 EX-10.1 d228038dex101.htm EX-10.1 179958
4 EX-10.2 d228038dex102.htm EX-10.2 98016
5 EX-99.1 d228038dex991.htm EX-99.1 11373
9 GRAPHIC g228038g0527114702087.jpg GRAPHIC 4102
  Complete submission text file 0001193125-26-241846.txt   620065

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA qttb-20260526.xsd EX-101.SCH 3175
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE qttb-20260526_lab.xml EX-101.LAB 17234
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qttb-20260526_pre.xml EX-101.PRE 10809
20 EXTRACTED XBRL INSTANCE DOCUMENT d228038d8k_htm.xml XML 3522
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 261026022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)